Last reviewed · How we verify
Citalopram p.o
At a glance
| Generic name | Citalopram p.o |
|---|---|
| Sponsor | Istituto Auxologico Italiano |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- REward Processing And Citalopram Study (PHASE1, PHASE2)
- Potential Predictive Biological Markers of Major Depression Response to Citalopram Therapy in Anorexia Nervosa.
- Effectiveness Study of Scopolamine Combined With Escitalopram in Patients With MDD (PHASE4)
- Lexapro®'s Efficacy After Dose Escalation in Remission Study (PHASE4)
- Neural, Genetic, and Peripheral Correlates of SSRI Pharmaco-Response (PHASE4)
- EScitalopram PIndolol ONset of Action (PHASE2, PHASE3)
- Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression (PHASE4)
- A PET Study to Determine Alterations in Serotonin Levels in Human Brain After a Single Dose of Escitalopram (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |